Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 21 December, 2024
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 542934 | NSE: CBPL

Chandra Bhagat Pharma Ltd: Fundamental Analysis, Share Price Insights & Intrinsic Value (2024)

Share Price and Basic Stock Data

Last Updated: December 21, 2024, 8:28 pm

Market Cap 49.0 Cr.
Current Price 65.0
High / Low 148/63.0
Stock P/E31.0
Book Value 39.4
Dividend Yield0.00 %
ROCE7.95 %
ROE5.42 %
Face Value 10.0
PEG Ratio0.82

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for

Competitors of

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Gujarat Themis Biosyn Ltd 3,354 Cr. 308 390/12863.6 20.50.22 %45.0 %33.8 % 1.00
Gujarat Terce Laboratories Ltd 62.6 Cr. 84.4 94.9/26.624.0 11.90.00 %9.72 %3.44 % 10.0
Gujarat Inject (Kerala) Ltd 35.9 Cr. 24.5 24.5/8.7446.6 6.640.00 %2.65 %2.08 % 10.0
Godavari Drugs Ltd 86.7 Cr. 115 155/87.013.0 55.40.00 %14.4 %15.5 % 10.0
Glenmark Life Sciences Ltd 12,416 Cr. 1,013 1,335/64529.3 2072.22 %28.1 %21.1 % 2.00
Industry Average19,016.52 Cr1,181.3156.05186.300.32%16.20%16.32%6.27

All Competitor Stocks of

Quarterly Result

MonthSep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024
Sales224843514475119102
Expenses214742504374124104
Operating Profit222112-5-2
OPM %7%3%4%2%2%2%-4%-2%
Other Income00011074
Interest22121111
Depreciation00000000
Profit before tax00111111
Tax %25%33%24%31%31%15%32%34%
Net Profit00000111
EPS in Rs0.040.210.570.480.490.720.831.19

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Sales354861809097106947194120221
Expenses354658768592102916791116228
Operating Profit02334553433-7
OPM %1%4%5%4%5%5%4%3%5%3%3%-3%
Other Income0100010002011
Interest022344434321
Depreciation000000000001
Profit before tax001112100112
Tax %27%17%39%51%27%33%22%26%32%27%22%33%
Net Profit000011100112
EPS in Rs9.608.3710.298.3715.7924.6410.290.410.251.061.212.03
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2017-20182018-20192019-20202022-20232023-2024
YoY Net Profit Growth (%)0.00%0.00%-100.00%0.00%100.00%
Change in YoY Net Profit Growth (%)0.00%0.00%-100.00%100.00%100.00%

has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2017-2018 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:17%
5 Years:16%
3 Years:46%
TTM:-14%
Compounded Profit Growth
10 Years:16%
5 Years:17%
3 Years:100%
TTM:35%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:-11%
1 Year:-51%
Return on Equity
10 Years:4%
5 Years:3%
3 Years:4%
Last Year:5%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 5:35 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital0.250.420.420.420.420.420.67888888
Reserves36667814181819202122
Borrowings11192828222231302721191623
Other Liabilities97810262837191925145642
Total Liabilities243242445658837572726110295
Fixed Assets1111110000132
CWIP0000000000000
Investments0000514100001
Other Assets23314144515678747172609992
Total Assets243242445658837572726110295

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +0000-9-64-781256
Cash from Investing Activity +00000-0-0000-0-2
Cash from Financing Activity +000087-47-6-10-4-6
Net Cash Flow0000-1-0-0-0231-1

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-11.00-17.00-25.00-25.00-18.00-17.00-26.00-27.00-23.00-18.00-16.00-23.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days856571668067905480582565
Inventory Days16117712313314517418721515310015
Days Payable53433381691175379121123
Cash Conversion Cycle8517420515613214314618821619911457
Working Capital Days10714916613412513813921225816512161
ROCE %2%12%10%10%15%17%13%7%7%9%7%8%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024
Promoters70.42%70.42%71.80%71.80%70.11%69.09%68.24%68.69%68.77%69.29%
FIIs0.00%0.00%0.00%0.00%0.00%0.85%0.85%1.33%1.33%0.48%
DIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.89%0.89%0.00%
Public29.58%29.58%28.20%28.20%29.89%30.07%30.91%29.09%29.02%30.23%
No. of Shareholders17815610690126126146134152315

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)2.031.201.060.250.55
Diluted EPS (Rs.)2.031.201.060.250.55
Cash EPS (Rs.)2.881.551.220.290.45
Book Value[Excl.RevalReserv]/Share (Rs.)38.4536.4235.3534.3034.05
Book Value[Incl.RevalReserv]/Share (Rs.)38.4536.4235.3534.3034.05
Revenue From Operations / Share (Rs.)293.40158.61124.6893.70124.56
PBDIT / Share (Rs.)5.694.795.691.054.66
PBIT / Share (Rs.)4.844.445.531.014.62
PBT / Share (Rs.)3.001.541.450.360.55
Net Profit / Share (Rs.)2.031.201.050.250.41
PBDIT Margin (%)1.933.014.561.123.73
PBIT Margin (%)1.642.794.431.073.70
PBT Margin (%)1.020.971.160.390.44
Net Profit Margin (%)0.690.750.840.260.33
Return on Networth / Equity (%)5.273.292.980.731.22
Return on Capital Employeed (%)11.869.9512.121.958.56
Return On Assets (%)1.501.491.090.260.42
Long Term Debt / Equity (X)0.040.140.200.360.42
Total Debt / Equity (X)0.560.680.740.961.07
Asset Turnover Ratio (%)2.731.801.300.961.19
Current Ratio (X)1.382.191.862.132.14
Quick Ratio (X)1.261.110.961.060.85
Inventory Turnover Ratio (X)1.540.530.070.230.00
Interest Coverage Ratio (X)3.091.651.401.651.15
Interest Coverage Ratio (Post Tax) (X)2.101.411.261.391.10
Enterprise Value (Cr.)83.1485.6999.9252.5457.63
EV / Net Operating Revenue (X)0.370.711.060.740.61
EV / EBITDA (X)19.3823.7123.2666.0216.40
MarketCap / Net Operating Revenue (X)0.320.610.910.420.32
Price / BV (X)2.472.663.221.151.17
Price / Net Operating Revenue (X)0.320.610.910.420.32
EarningsYield0.020.010.010.010.01

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of as of December 21, 2024 is: 67.52

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of December 21, 2024, is Undervalued by 3.88% compared to the current share price 65.00

Intrinsic Value of as of December 21, 2024 is: 92.98

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of December 21, 2024, is Undervalued by 43.05% compared to the current share price 65.00

Last 5 Year EPS CAGR: 37.70%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has shown consistent growth in sales (93.08 cr) and profit (0.83 cr) over the years.
  1. The stock has a low average ROCE of 9.75%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 147.92, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 151.25, which may not be favorable.
  4. The company has higher borrowings (22.85) compared to reserves (12.92), which may suggest financial risk.
  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in :
    1. Net Profit Margin: 0.69%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 11.86% (Industry Average ROCE: 16.2%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 5.27% (Industry Average ROE: 16.32%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 2.1
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.26
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 31 (Industry average Stock P/E: 56.05)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.56
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Chandra Bhagat Pharma Ltd. is a Public Limited Listed company incorporated on 10/03/2003 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH2003PLC139534 and registration number is 139534. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 94.08 Cr. and Equity Capital is Rs. 7.55 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Pharmaceuticals323-F Bhagat Bhuvan, Mumbai Maharashtra 400019compliancecbc@gmail.com
http://www.cbcpharma.com
Management
NamePosition Held
Mr. Hemant Chandravadan BhagatChairman & Managing Director
Mr. Pranav Hemant BhagatWhole Time Director
Mrs. Prachi Pranav BhagatDirector & CFO
Mr. Ravindra Gajanan AwatiIndependent Director
Ms. Abha Praveen DoshiIndependent Director

FAQ

What is the latest intrinsic value of ?

The latest intrinsic value of as on 21 December 2024 is ₹67.52, which is 3.88% higher than the current market price of ₹65.00. The stock has a market capitalization of 49.0 Cr. and recorded a high/low of 148/63.0 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹22 Cr and total liabilities of ₹95 Cr.

What is the Market Cap of ?

The Market Cap of is 49.0 Cr..

What is the current Stock Price of as on 21 December 2024?

The current stock price of as on 21 December 2024 is 65.0.

What is the High / Low of stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of stocks is 148/63.0.

What is the Stock P/E of ?

The Stock P/E of is 31.0.

What is the Book Value of ?

The Book Value of is 39.4.

What is the Dividend Yield of ?

The Dividend Yield of is 0.00 %.

What is the ROCE of ?

The ROCE of is 7.95 %.

What is the ROE of ?

The ROE of is 5.42 %.

What is the Face Value of ?

The Face Value of is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in . Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE